Ex vivo dual gene therapy using human adipocytes secreting anti-HER2 antibody on HER2-positive xenograft tumor models

被引：0
作者：
Ryotaro Teranaka
Hiroshi Fujimoto
Takahito Masuda
Masayuki Kuroda
Yasuyuki Aoyagi
Takeshi Nagashima
Mamoru Takada
Junta Sakakibara
Hideyuki Yamada
Hiroto Yamamoto
Yoshitaka Kubota
Masayuki Ohtsuka
机构：
[1] Chiba University Graduate School of Medicine,Department of General Surgery
[2] Chiba University Hospital,Center for Advanced Medicine
[3] CellGenTech,Department of Plastic, Reconstructive, and Aesthetic Surgery
[4] Inc.,undefined
[5] Chiba University Graduate School of Medicine,undefined
来源：
Breast Cancer | 2023年 / 30卷
关键词：
Breast cancer; Adipocytes; Gene therapy; Human epidermal growth factor receptor 2; Molecular target therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1018 / 1027
页数：9
相关论文
共 50 条
  • [31] Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells
    Damiani, Isabella
    Castiglioni, Silvia
    Sochaj-Gregorczyk, Alicja
    Bonacina, Fabrizia
    Colombo, Irma
    Rusconi, Valentina
    Otlewski, Jacek
    Corsini, Alberto
    Bellosta, Stefano
    [J]. BIOLOGY-BASEL, 2021, 10 (08):
  • [32] PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy
    Mattia Barbareschi
    Lucia Veronica Cuorvo
    Salvatore Girlando
    Emma Bragantini
    Claudio Eccher
    Elena Leonardi
    Antonella Ferro
    Alessia Caldara
    Renza Triolo
    Chiara Cantaloni
    Nicola Decarli
    Enzo Galligioni
    Paolo Dalla Palma
    [J]. Virchows Archiv, 2012, 461 : 129 - 139
  • [33] Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens
    Azadeh Nasrazadani
    Juan Luis Gomez Marti
    Kate Lathrop
    Alvaro Restrepo
    Szu-Yun Leu
    Gajanan Bhat
    Adam Brufsky
    [J]. Breast Cancer Research and Treatment, 2024, 205 : 29 - 37
  • [34] Poziotinib treatment in patients with HER2-positive advanced breast cancer who have received prior anti-HER2 regimens
    Nasrazadani, Azadeh
    Marti, Juan Luis Gomez
    Lathrop, Kate
    Restrepo, Alvaro
    Leu, Szu-Yun
    Bhat, Gajanan
    Brufsky, Adam
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (01) : 29 - 37
  • [35] A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo
    Yan, Yan
    Cheng, Xiao
    Li, Lin
    Zhang, Rumeng
    Zhu, Yong
    Wu, Zhengsheng
    Ding, Keshuo
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] In vivo breast cancer cell imaging using quantum dot conjugated with anti-HER2 antibody
    Tada, Hiroshi
    Higuchi, Hideo
    Watanabe, Tomonobu M.
    Ohuchi, Noriaki
    [J]. FUTURE MEDICAL ENGINEERING BASED ON BIONANOTECHNOLOGY, PROCEEDINGS, 2006, : 515 - +
  • [37] Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model
    Tong, Yiwei
    Hu, Zhaoyu
    Wang, Haoyu
    Huang, Jiahui
    Zhan, Ying
    Chai, Weimin
    Deng, Yinhui
    Yuan, Ying
    Shen, Kunwei
    Wang, Yuanyuan
    Chen, Xiaosong
    Yu, Jinhua
    [J]. EUROPEAN RADIOLOGY, 2024, 34 (08) : 5477 - 5486
  • [38] Anti-HER2 therapy response assessment for guiding treatment (de-)escalation in early HER2-positive breast cancer using a novel deep learning radiomics model
    Tong, Yiwei
    Hu, Zhaoyu
    Wang, Haoyu
    Huang, Jiahui
    Zhan, Ying
    Chai, Weimin
    Deng, Yinhui
    Yuan, Ying
    Shen, Kunwei
    Wang, Yuanyuan
    Chen, Xiaosong
    Yu, Jinhua
    [J]. EUROPEAN RADIOLOGY, 2024, 34 (8) : 5477 - 5486
  • [39] Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody-Drug Radioconjugate
    Pougoue Ketchemen, Jessica
    Njotu, Fabrice Ngoh
    Babeker, Hanan
    Monzer, Alissar
    Nwangele, Emmanuel
    Tikum, Anjong Florence
    Henning, Nikita
    Hassani, Nava
    Frye, Sarah
    Perron, Randy
    Byrne, Chris
    Didychuk, Candice
    Qi, Qi
    Bannister, Laura
    Doroudi, Alireza
    Fonge, Humphrey
    [J]. CLINICAL CANCER RESEARCH, 2025, 31 (04) : 685 - 696
  • [40] HER2-positive breast cancer, how far away from the cure?-on the current situation of anti-HER2 therapy in breast cancer treatment and survival of patients
    Liao, Ning
    [J]. CHINESE CLINICAL ONCOLOGY, 2016, 5 (03)
12345